Ending Parkinson’s Disease: A Prescription for Action authors speak to Parkinson’s Life about their plans to help those with the condition
Parkinson’s experts have revealed their plan to “prevent, advocate, care and treat” the condition ahead of the launch of their new book, Ending Parkinson’s Disease: A Prescription for Action.
Credits: Ending Parkinson's Disease: A Prescription for Action
With Parkinson’s now the world’s fastest-growing brain disorder and one in 37 people alive today predicted to be diagnosed with the condition in their lifetime, the new book addresses how we can prevent its increase.
Authors Dr Ray Dorsey, Dr Todd Sherer, Dr Michael Okun and Dr Bastiaan Bloem, who have devoted their careers to studying Parkinson’s, spoke to Parkinson’s Life about the launch.
Dr Bloem, professor of neurology and medical director at Radboud University Medical Centre, the Netherlands, said: “We draw attention to the rapid rise in numbers of new patients with Parkinson’s, making this the fastest growing neurological condition on the planet. Our plan of action is to take measures to help prevent new people from developing the condition in the future, and to ascertain better treatments and care for the millions of people affected today.”
The team believe now is time to act more aggressively to end Parkinson’s disease, Dr Okun said.
He added: “The cost of falls, fractures and nursing home placements will economically collapse most health care systems as the numbers of patients with Parkinson’s continues to skyrocket. We need to act now and change the trajectory.”
Ending Parkinson’s Disease: A Prescription for Action (£20, PublicAffairs) will be published on 16 April. Find out more about the book here.
Would you like the opportunity to read and review the book for the EPDA? We have five copies of Ending Parkinson’s Disease: A Prescription for Action to give away. In return, we will ask you to answer a few questions telling us what you thought of the book, which we’ll share on our website. If you’d like to be in with the chance to receive a copy in exchange for your feedback, please contact us at firstname.lastname@example.org with the subject line ‘Book Review’.
Read the full interview on Parkinson’s Life.
Which changes would you most like to see for advocacy and treatment of Parkinson’s? Email email@example.com and tell us your stories.
The EPDA is sharing this article for information purposes only; it does not represent the EPDA’s views and is not an endorsement by the EPDA of any particular treatments, therapies or products.